Inventor
Jian Liu
Inventor
Edison, NJ, US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes23%
G06FElectric digital data processing2%
A61QSpecific use of cosmetics or similar toiletry preparations1%
C07CAcyclic or carbocyclic compounds1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07HSugars1%
C07KPeptides1%
G06KGraphical data reading1%
PatentTitleYear
11,100,047Method, device and computer program product for deleting snapshots202111,087,140Information generating method and apparatus applied to terminal device202110,246,457Indazole and azaindazole Btk inhibitors201910,214,546Btk inhibitors201910,208,047Tertiary alcohol imidazopyrazine BTK inhibitors201910,130,630BTK inhibitors201810,087,188Benzamide imidazopyrazine Btk inhibitors201810,040,805Substituted imidazo[1,5-a]pyrazines as Btk inhibitors20189,981,970Bicyclic ureas and thiadiazolidine-1, 1-dioxides as CETP inhibitors20189,834,554BTK inhibitors20179,718,828'BTK Inhibitors'20179,637,486'Btk inhibitors'20179,481,682'Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors'20169,446,130'BTK inhibitors'20169,346,825'Fused bicyclic oxazolidinone CETP inhibitor'20168,871,738'Fused bicyclic oxazolidinone CETP inhibitor'20148,796,256'Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators'20148,754,099'Oxadiazole beta carboline derivatives as antidiabetic compounds'20148,697,652'Cosmetic use of at least the natural tetrapeptide Ac-Ser-Asp-Lys-Pro or one of its analogs as a skin restructuring agent'20148,318,767'Substituted imidazoles as bombesin receptor subtype-3 modulators'20128,293,900'Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators'20128,273,768'Iso CA-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization'20128,183,275'Substituted imidazoles as bombesin receptor subtype-3 modulators'20128,106,070'Substituted imidazoles as bombesin receptor subtype-3 modulators'20127,951,829'Benzimidazole modulators of VR1'20117,608,622'Imidazo[4,5-b]pyrazinone inhibitors of protein kinases'20097,329,673'Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists'20087,326,788'Quinolinone derivatives as inhibitors of c-fms kinase'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2014Patents assigned to JANSSEN PHARMACEUTICA NV (4)· patent assignee history
2008–2019Based in Edison, NJ, US· patent location history
2008–2009Based in Plainsboro, NJ, US· patent location history
2011–2014Based in Manalapan, NJ, US· patent location history
2012–2019Patents assigned to MERCK SHARP & DOHME (19)· patent assignee history
2012–2019Patents assigned to LIU JIAN (8)· patent assignee history
2012–2014Patents assigned to NARGUND RAVI P (5)· patent assignee history
2012Patents assigned to FRANKLIN CHRISTOPHER L (3)· patent assignee history
2014Based in Ivry, FR· patent location history
2021Based in Beijing, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 19 | 2012–2019 |
| LIU JIANself | 8 | 2012–2019 |
| NARGUND RAVI P | 5 | 2012–2014 |
| JANSSEN PHARMACEUTICA NV | 4 | 2008–2014 |
| FRANKLIN CHRISTOPHER L | 3 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Edison, New Jersey, US | 20 | 2008–2019 |
| Beijing, CN | 2 | 2021 |
| Manalapan, New Jersey, US | 2 | 2011–2014 |
| Plainsboro, New Jersey, US | 2 | 2008–2009 |
| Ivry, FR | 1 | 2014 |